Biomimetic materials for controlling bone cell responses

Frontiers in Bioscience - Scholar

Volumn 5 S, Issue 1, 2013, Pages 369-395

  Drevelle, Olivier ^a   Faucheux, Nathalie ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

BMP; Bone cells; Bone substitute; Ceramics; Extracellular matrix; Integrin; Osteoconduction; Osteoinduction; Peptide; Polymer; Review

Indexed keywords

BIOCERAMICS; BIOMIMETIC MATERIAL; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; CALCIUM ION; CALCIUM PHOSPHATE CERAMIC; CHITOSAN; COLLAGEN; COLLAGEN FIBRIL; COPOLYMER; FIBRIN; FIBRONECTIN; HYALURONIC ACID; INTEGRIN; MACROGOL; MAGNESIUM ION; MULTI WALLED NANOTUBE; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEONECTIN; OSTEOPONTIN; POLYCAPROLACTONE; POLYGLACTIN; PROTEOGLYCAN; SPHINGOSINE 1 PHOSPHATE; THROMBOSPONDIN; TISSUE SCAFFOLD; TRANSCRIPTION FACTOR NFAT; BIOMATERIAL;

ADSORPTION; BIODEGRADATION; BONE CELL; BONE CONDUCTION; BONE DEFECT; BONE DENSITY; BONE MATRIX; BONE MINERALIZATION; BONE PROSTHESIS; BONE REGENERATION; BONE REMODELING; BONE TURNOVER; CARTILAGE CELL; CELL ADHESION; CELL FUNCTION; CELL RESPONSE; CERAMICS; COMPOSITE MATERIAL; COMPRESSIVE STRENGTH; COVALENT BOND; FRACTURE; HIP ARTHROPLASTY; HUMAN; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOCYTE; OSTEOID; OSTEOLYSIS; PROTEIN EXPRESSION; REVIEW; STATIC ELECTRICITY; SYSTEMATIC REVIEW; YOUNG MODULUS; ANIMAL; BONE; DRUG EFFECT; PHYSIOLOGY;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOMIMETIC MATERIALS; BONE AND BONES; BONE REGENERATION; BONE SUBSTITUTES; HUMANS;

EID: 84883712499     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/s378     Document Type: Review

References (249)

1. A. Del Fattore, M. Capannolo and N. Rucci: Bone and bone marrow: The same organ. Arch Biochem Biophys 503, 28-34 (2010)
2. R. H. Li and J.M. Wozney: Delivering on the promise of bone morphogenetic proteins. Trends Biotechnol 19, 255-265 (2001)
3. P. V. Giannoudis, H. Dinopoulos and E. Tsiridis: Bone substitutes: An update. Injury 36, S20-S27 (2005)
4. S. Asamura, Y. Ikada, K. Matsunaga, M. Wada and N. Isogai: Treatment of orbital floor fracture using a periosteumpolymer complex. J Craniomaxillofac Surg 38, 197-203 (2010)
5. R. J. Bruno, M. S. Cohen, A. Berzins and D. R. Sumner: Bone graft harvesting from the distal radius, olecranon, and iliac crest: A quantitative analysis. J Hand Surg 26, 135-141 (2001)
6. J. D. Conway: Autograft and nonunions: morbidity with intramedullary bone graft versus iliac crest bone graft. Orthop Clin North Am 41, 75-84 (2010)
7. S. M. Graham, A. Leonidou, N. Aslam-Pervez, A. Hamza, P. Panteliadis, M. Heliotis, A. Mantalaris and E. Tsiridis: Biological therapy of bone defects: the immunology of bone allo-Transplantation. Expert Opin Biol Ther 10, 885-901 (2010)
8. M. Locke: Structure of long bones in mammals. J Morphol 262, 546-565 (2004)
9. R. B. Martin: Targeted bone remodeling involves BMU steering as well as activation. Bone 40, 1574-1580 (2007)
10. E. J. Mackie: Osteoblasts: novel roles in orchestration of skeletal architecture. Int J Biochem Cell Biol 35, 1301-1305 (2003)
11. T. J. Heino, K. Kurata, H. Higaki and H. K.Väänänen: Evidence for the role of osteocytes in the initiation of targeted remodeling. Technol Health Care 17, 49-56 (2009)
12. H. Yasuda, N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, S.-i. Mochizuki, A. Tomoyasu, K. Yano, M. Goto, A. Murakami, E. Tsuda, T. Morinaga, K. Higashio, N. Udagawa, N. Takahashi and T. Suda: Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci 95, 3597-3602 (1998)
13. L. E. Theill, W. J. Boyle and J. M. Penninger: RANK-L AND RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol 20, 795-823 (2002)
14. F. Arai, T. Miyamoto, O. Ohneda, T. Inada, T. Sudo, K. Brasel, T. Miyata, D. M. Anderson and T. Suda: Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor KB (RANK) receptors. J Exp Med 190, 1741-1754 (1999)
15. H. Takayanagi, S. Kim, T. Koga, H. Nishina, M. Isshiki, H. Yoshida, A. Saiura, M. Isobe, T. Yokochi, J.-i. Inoue, E. F. Wagner, T. W. Mak, T. Kodama and T. Taniguchi: Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3, 889-901 (2002)
16. L. J. Raggatt and N. C. Partridge: Cellular and molecular mechanisms of bone remodeling. J Biol Chem 285, 25103-25108 (2010)
17. E. D. Jensen, L. Pham, C. J. Billington, K. Espe, A. E. Carlson, J. J. Westendorf, A. Petryk, R. Gopalakrishnan and K. Mansky: Bone morphogenic protein 2 directly enhances differentiation of murine osteoclast precursors. J Cell Biochem 109, 672-682 (2010)
18. M. Ishii, J. G. Egen, F. Klauschen, M. Meier-Schellersheim, Y. Saeki, J. Vacher, R.L. Proia and R. N. Germain: Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature 458, 524-528 (2009)
19. M. Ishii, J. Kikuta, Y. Shimazu, M. Meier-Schellersheim and R. N. Germain: Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo. J Exp Med 207, 2793-2798 (2010)
20. Y. Okada, I. Morimoto, K. Ura, K. Watanabe, S. Eto, M. Kumegawa, L. Raisz, C. Pilbeam and Y. Tanaka: Cellto-cell adhesion via intercellular adhesion molecule-1 and leukocyte function-Associated antigen-1 pathway is involved in 1alpha,25(OH)2D3, PTH and IL-1alpha-induced osteoclast differentiation and bone resorption. Endocr J 49, 483-495 (2002)
21. M. Stolina, G. Schett, D. Dwyer, S. Vonderfecht, S. Middleton, D. Duryea, E. Pacheco, G. Van, B. Bolon, U. Feige, D. Zack and P. Kostenuik: RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies. Arthritis Res Ther 11, R187 (2009)
22. S. C. Manolagas: Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21, 115-137 (2000)
23. M. Pérez-Sayáns, J. M. Somoza-Martin, F. Barros-Angueira, J. M. G. Rey and A. Garcia-Garcia: RANK/RANKL/OPG role in distraction osteogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109, 679-686 (2010)
24. E. F. Eriksen: Cellular mechanisms of bone remodeling. Rev Endoc Metab Disord 11, 219-227 (2010)
25. M. Du, J. Yin and M. J. Zhu: Cellular signaling pathways regulating the initial stage of adipogenesis and marbling of skeletal muscle. Meat Sci 86, 103-109 (2010)
26. S.-i. Harada and G. A. Rodan: Control of osteoblast function and regulation of bone mass. Nature 423, 349-355 (2003)
27. K. Mori, R. Kitazawa, T. Kondo, S. Maeda, A. Yamaguchi and S. Kitazawa: Modulation of mouse RANKL gene expression by Runx2 and PKA pathway. J Cell Biochem 98, 1629-1644 (2006)
28. R. Kitazawa, K. Mori, A. Yamaguchi, T. Kondo and S. Kitazawa: Modulation of mouse RANKL gene expression by Runx2 and vitamin D3. J Cell Biochem 105, 1289-1297 (2008)
29. N. Holleville, S. Matéos, M. Bontoux, K. Bollerot and A. H. Monsoro-Burq: Dlx5 drives Runx2 expression and osteogenic differentiation in developing cranial suture mesenchyme. Dev Biol 304, 860-874 (2007)
30. M. Hughes-Fulford and C.-F. Li: The role of FGF-2 and BMP-2 in regulation of gene induction, cell proliferation and mineralization. J Orthop Surg Res 6, 1-8 (2011)
31. F. Kugimiya, S. Ohba, K. Nakamura, H. Kawaguchi, and U.-i. Chung: Physiological role of bone morphogenetic proteins in osteogenesis. J Bone Miner Metab 24, 95-99 (2006)
32. K. S. Lee, H. J. Kim, Q. L. Li, X. Z. Chi, C. Ueta, T. Komori, J. M. Wozney, E. G. Kim, J. Y. Choi, H. M. Ryoo and S. C. Bae: Runx2 is a common target of transforming growth factor beta 1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblastspecific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 20, 8783-8792 (2000)
33. H. Cheng, W. Jiang, F. M. Phillips, R. C. Haydon, Y. Peng, L. Zhou, H. H. Luu, N. An, B. Breyer, P. Vanichakarn, J. P. Szatkowski, J. Y. Park and T.-C. He: Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 85A, 1544-1552 (2003)
34. Q. Kang, M. H. Sun, H. Cheng, Y. Peng, A. G. Montag, A. T. Deyrup, W. Jiang, H. H. Luu, J. Luo, J. Szatkowski, P. Vanichakarn, J. Y. Park, Y. Li, R. C. Haydon and T. C. He: Characterization of the distinct orthotopic boneforming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther 11, 1312-1320 (2004)
35. A. Wutzl, M. Rauner, R. Seemann, W. Millesi, P. Krepler, P. Pietschmann and R. Ewers: Bone morphogenetic proteins 2, 5, and 6 in combination stimulate osteoblasts but not osteoclasts in vitro. J Orthop Res 28, 1431-1439 (2010)
36. N. K. Kanakaris, G. M. Calori, R. Verdonk, P. Burssens, P. De Biase, R. Capanna, L. B. Vangosa, P. Cherubino, F. Baldo, J. Ristiniemi, G. Kontakis and P. V. Giannoudis: Application of BMP-7 to tibial non-unions: A 3-year multicenter experience. Injury, Int. J. Care Injured 39, S83-S90 (2008)
37. I. Fernandez-Tresguerres Hernandez-Gil, M. A. Alobera Gracia, M. del Canto Pingarron and L. Blanco Jerez: Physiological bases of bone regeneration I. Histology and physiology of bone tissue. Med Oral Patol Oral Cir Bucal 11, E47-E51 (2006)
38. F. Shapiro: Cortical bone repair. The relationship of the lacunar-canalicular system and intercellular gap junctions to the repair process. J Bone Joint Surg Am. 70, 1067-1081 (1988)
39. M. L. Knothe Tate, J. R. Adamson, A. E. Tami and T. W. Bauer: The osteocyte. Int J Biochem Cell Biol 36, 1-8 (2004)
40. B. Noble: Bone microdamage and cell apoptosis. Eur Cell Mater 6, 46-56 (2003)
41. N. L. Hedgecock, T. Hadi, A. A. Chen, S. B. Curtiss, R. B. Martin and S. J. Hazelwood: Quantitative regional associations between remodeling, modeling, and osteocyte apoptosis and density in rabbit tibial midshafts. Bone 40, 627-637 (2007)
42. G. Kogianni, V. Mann and B. S. Noble: Apoptotic bodies convey activity capable of initiating osteoclastogenesis and localized bone destruction. J Bone Miner Res 23, 915-927 (2008)
43. L. E. Mulcahy, D. Taylor, T.C. Lee and G. P. Duffy: RANKL and OPG activity is regulated by injury size in networks of osteocyte-like cells. Bone 48, 182-188 (2011)
44. C. Krause, O. Korchynskyi, K. de Rooij, S. E. Weidauer, D. J. J. de Gorter, R. L. van Bezooijen, S. Hatsell, A. N. Economides, T. D. Mueller, C. W. G. M. Löwik and P. ten Dijke: Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways. J Biol Chem 285, 41614-41626 (2010)
45. K. Gelse, E. Pöschl and T. Aigner: Collagens-structure, function, and biosynthesis. Adv Drug Deliv Rev 55, 1531-1546 (2003)
46. H. D. Espinosa, J. E. Rim, F. Barthelat and M. J. Buehler: Merger of structure and material in nacre and bone-Perspectives on de novo biomimetic materials. Prog Mater Sci 54, 1059-1100 (2009)
47. S. Perumal, O. Antipova and J. P. R. O. Orgel: Collagen fibril architecture, domain organization, and triple-helical conformation govern its proteolysis. Proc Natl Acad Sci U S A 105, 2824-2829 (2008)
48. J. P. R. O. Orgel, O. Antipova, I. Sagi, A. Bitler, D. Qiu, R. Wang, Y. Xu and J. D. San Antonio: Collagen fibril surface displays a constellation of sites capable of promoting fibril assembly, stability, and hemostasis. Connect Tissue Res 52, 18-24 (2011)
49. M. Tzaphlidou: The role of collagen in bone structure: An image processing approach. Micron 36, 593-601 (2005)
50. A. Gautieri, S. Vesentini, A. Redaelli and M. J. Buehler: Hierarchical structure and nanomechanics of collagen microfibrils from the atomistic scale up. Nanoletters 11, 757-766 (2011)
51. M.-E. Marquis, E. Lord, E. Bergeron, O. Drevelle, H. Park, F. Cabana, H. Senta and N. Faucheux: Bone cells-biomaterials interactions. Front Biosci 14, 1023-1067 (2009)
52. P. Grafenau, B. Carstanjen and O. M. Lepage: Osteocalcin: a biochemical marker of bone formation in equine medicine. Vet Med 45, 209-216 (2000)
53. Q. Q. Hoang, F. Sicheri, A. Howard and D. S. C. Yang: Bone recognition mechanism of porcine osteocalcin from crystal structure. Nature 425, 977-980 (2003)
54. A. J. Lee, S. Hodges and R. Eastell: Measurement of osteocalcin. Ann Clin Biochem 37, 432-446 (2000)
55. M. Ishida and S. Amano: Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation. J Bone Miner Metab 22, 415-429 (2004)
56. J. Sodek, B. Zhu, M. H. Huynh, T. J. Brown and M. Ringuette: Novel functions of the matricellular proteins osteopontin and osteonectin/SPARC. Connect Tissue Res 43, 308-319 (2002)
57. X. C. Villarreal, K. G. Mann and G. L. Long: Structure of human osteonectin based upon analysis of cDNA and genomic sequences. Biochem 28, 6483-6491 (1989)
58. A. I. Alford and K. D. Hankenson: Matricellular proteins: Extracellular modulators of bone development, remodeling, and regeneration. Bone 38, 749-757 (2006)
59. C. Qin, O. Baba and W. T. Butler: Post-Translational modifications of SIBLING proteins and their roles in osteogenesis and dentinogenesis. Crit Rev Oral Biol Med 15, 126-136 (2004)
60. P. Valverde, Q. Tu and J. Chen: BSP and RANKL induce osteoclastogenesis and bone resorption synergistically. J Bone Miner Res 20, 1669-1679 (2005)
61. Y. Yang, Q. Cui and N. Sahai: How does bone sialoprotein promote the nucleation of hydroxyapatite? A molecular dynamics study using model peptides of different conformations. Langmuir 26, 9848-9859 (2010)
62. Y. Bi, K. L. Nielsen, T. M. Kilts, A. Yoon, M.A. Karsdal, H. F. Wimer, E. M. Greenfield, A. M. Heegaard and M. F. Young: Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts. Bone 38, 778-786 (2006)
63. Y. Mochida, D. Parisuthiman, S. Pornprasertsuk-Damrongsri, P. Atsawasuwan, M. Sricholpech, A. L. Boskey and M. Yamauchi: Decorin modulates collagen matrix assembly and mineralization. Matrix Biol 28, 44-52 (2009)
64. R. Pankov and K. M. Yamada: Fibronectin at a glance. J Cell Sci 115, 3861-3863 (2002)
65. A. Gramoun, N. Azizi, J. Sodek, J. N. M. Heersche, I. Nakchbandi and M. F. Manolson: Fibronectin inhibits osteoclastogenesis while enhancing osteoclast activity via nitric oxide and interleukin-1b-mediated signaling pathways. J Cell. Biochem 111, 1020-1034 (2010)
66. B. Huang, Y. Sun, I. Maciejewska, D. Qin, T. Peng, B. McIntyre, J. Wygant, W. T. Butler and C. Qin: Distribution of SIBLING proteins in the organic and inorganic phases of rat dentin and bone. Eur J Oral Sci 116, 104-112 (2008)
67. H. I. Roach: Why does bone matrix contain noncollagenous proteins? The possible roles of osteocalcin, osteonectin, osteopontin and bone sialoprotein in bone mineralisation and resorption. Cell Biol Int 18, 617-628 (1994)
68. C. E. Tye, K. R. Rattray, K. J. Warner, J. A. R. Gordon, J. Sodek, G. K. Hunter and H. A. Goldberg: Delineation of the hydroxyapatite-nucleating domains of bone sialoprotein. J Biol Chem 278, 7949-7955 (2003)
69. P. J. Thurner, C. G. Chen, S. Ionova-Martin, L. Sun, A. Harman, A. Porter, J. W. Ager III, R. O. Ritchie and T. Alliston: Osteopontin deficiency increases bone fragility but preserves bone mass. Bone 46, 1564-1573 (2010)
70. A. Ode, G. N. Duda, J. D. Glaeser, G. Matziolis, S. Frauenschuh, C. Perka, C. J. Wilson and G. Kasper: Toward biomimetic materials in bone regeneration: Functional behavior of mesenchymal stem cells on a broad spectrum of extracellular matrix components. J Biomed Mater Res A 95A, 1114-1124 (2010)
71. S. G. Rees, R. P. Shellis and G. Embery: Inhibition of hydroxyapatite crystal growth by bone proteoglycans and proteoglycan components. Biochem Biophys Res Commun 292, 727-733 (2002)
72. R. O. Hynes: Integrins: Bidirectional, allosteric signaling machines. Cell 110, 673-687 (2002)
73. E. Ruoslahti and M. D. Pierschbacher: New perspectives in cell adhesion: RGD and integrins. Science 238, 491-497 (1987)
74. A. Jikko, S. E. Harris, D. Chen, D. L. Mendrick and C. H. Damsky: Collagen integrin receptors regulate early osteoblast differentiation induced by BMP-2. J Bone Miner Res 14, 1075-1083 (1999)
75. M. H. Helfrich, S. A. Nesbitt, P. T. Lakkakorpi, M. J. Barnes, S. C. Bodary, G. Shankar, W. T. Mason, D. L. Mendrick, H. K. Väänänen and M. A. Horton: beta1 integrins and osteoclast function: Involvement in collagen recognition and bone resorption. Bone 19, 317-328 (1996)
76. S. B. Rodan and G. A. Rodan: Integrin function in osteoclasts. J Endocr 154, S47-S56 (1997)
77. C. F. Lai and S. L. Cheng: alphavbeta integrins play an essential role in BMP-2 induction of osteoblast differentiation. J Bone Miner Res 20, 330-340 (2005)
78. R. Faccio, D. V. Novack, A. Zallone, F. P. Ross and S. L. Teitelbaum: Dynamic changes in the osteoclast cytoskeleton in response to growth factors and cell attachment are controlled by beta3 integrin. J Cell Biol 162, 499-509 (2003)
79. R. Faccio, S. Takeshita, A. Zallone, F. P. Ross and S. L. Teitelbaum: c-Fms and the alphavbeta3 integrin collaborate during osteoclast differentiation. J Clin Invest 111, 749-758 (2003)
80. N. E. Lane, W. Yao, M. C. Nakamura, M. B. Humphrey, D. Kimmel, X. Huang, D. Sheppard, F. P. Ross and S. L. Teitelbaum: Mice lacking the integrin beta5 subunit have accelerated osteoclast maturation and increased activity in the estrogen-deficient state. J Bone Miner Res. 20, 58-66 (2005)
81. M. Inoue, F. P. Ross, J. M. Erdmann, Y. Abu-Amer, S. Wei and S. L. Teitelbaum: Tumor necrosis factor alpha regulates alphavbeta5 integrin expression by osteoclast precursors in vitro and in vivo. Endocrinol 141, 284-290 (2000)
82. D. V. Novack and R. Faccio: Osteoclast motility: Putting the brakes on bone resorption. Ageing Res Rev 10, 54-61 (2011)
83. S. K. Sastry, and K. Burridge: Focal adhesions: a nexus for intracellular signaling and cytoskeletal dynamics. Exp Cell Res 261, 25-36 (2000)
84. T. Volberg, L. Romer, E. Zamir and B. Geiger: pp60csrc and related tyrosine kinases: a role in the assembly and reorganization of matrix adhesions. J Cell Sci 114, 2279-2289 (2001)
85. F. Lüthen, R. Lange, P. Becker, J. Rychly, U. Beck and J. G. B. Nebe: The influence of surface roughness of titanium on beta1-And beta3-integrin adhesion and the organization of fibronectin in human osteoblastic cells. Biomaterials 26, 2423-2440 (2005)
86. P. Jurdic, F. Saltel, A. Chabadel and O. Destaing: Podosome and sealing zone: Specificity of the osteoclast model. Eur J Cell Biol 85, 195-202 (2006)
87. M. J. Oursler: Recent advances in understanding the mechanisms of osteoclast precursor fusion. J. Cell. Biochem.110, 1058-1062 (2010)
88. Y. Takeuchi, M. Suzawa, T. Kikuchi, E. Nishida, T. Fujita and T. Matsumoto: Differentiation and transforming growth factor-beta receptor down-regulation by collagenalpha2 beta1 integrin interaction is mediated by focal adhesion kinase and its downstream signals in murine osteoblastic cells. J Biol Chem 272, 29309-29316 (1997)
89. J. J. Worthington, J. E. Klementowicz and M. A. Travis: TGFbeta: a sleeping giant awoken by integrins. Trends Biochem Sci 36, 47-54 (2011)
90. J.L. Su, J. Chiou, C. H. Tang, M. Zhao, C. H. Tsai, P. S. Chen, Y. W. Chang, M. H. Chien, C. Y. Peng, M. Hsiao, M. L. Kuo and M. L. Yen: CYR61 regulates BMP-2-dependent osteoblast differentiation through the alphavbeta3 integrin/integrin-linked kinase/ERK pathway. J Biol Chem 285, 31325-31336 (2010)
91. U. Nöth, R. Tuli, R. Seghatoleslami, M. Howard, A. Shah, D. J. Hall, N. J. Hickok and R. S. Tuan: Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts. Exp Cell Res 291, 201-211 (2003)
92. R. Z. LeGeros, R. Kijkowska, C. Bautista and J. P. LeGeros: Synergistic effects of Magnesium and Carbonate on properties of biological and synthetic apatites. Connect Tissue Res 33, 203-209 (1995)
93. H. C. Anderson: Matrix vesicles and calcification. Curr Rheumatol Rep 5, 222-226 (2003)
94. K. Hoshi and H. Ozawa: Matrix vesicle calcification in bones of adult rats. Calcif Tissue Int 66, 430-434 (2000)
95. H. Orimo: The mechanism of mineralization and the role of alkaline phosphatase in health and disease. J Nippon Med Sch 77, 4-12 (2010)
96. R. Garimella, X. Bi, H. C. Anderson and N. P. Camacho: Nature of phosphate substrate as a major determinant of mineral type formed in matrix vesiclemediated in vitro mineralization: An FTIR imaging study. Bone 38, 811-817 (2006)
97. F. Nudelman, K. Pieterse, A. George, P. H. H. Bomans, H. Friedrich, L. J. Brylka, P. A. J. Hilbers, G. de With and N. A. J. M. Sommerdijk: The role of collagen in bone apatite formation in the presence of hydroxyapatite nucleation inhibitors. Nat Mater 9, 1004-1009 (2010)
98. W. J. Chung, K. Y. Kwon, J. Song and S.W. Lee: Evolutionary screening of collagen-like peptides that nucleate hydroxyapatite crystals. Langmuir 27, 7620-7628 (2011)
99. R. K. Rude and H. E. Gruber: Magnesium deficiency and osteoporosis: animal and human observations. J Nutr Biochem 15, 710-716 (2004)
100. P. J. Marie: The calcium-sensing receptor in bone cells: A potential therapeutic target in osteoporosis. Bone 46, 571-576 (2010)
101. M. Kanatani, T. Sugimoto, M. Kanzawa, S. Yano and K. Chihara: High extracellular calcium inhibits osteoclastlike cell formation by directly acting on the calciumsensing receptor existing in osteoclast precursor cells. Biochem Biophys Res Commun 261, 144-148 (1999)
102. M. Pi, T. K. Hinson and L. D. Quarles: Failure to detect the extracellular calcium-sensing receptor (CasR) in human osteoblast cell lines. J Bone Miner Res 14, 1310-1319 (1999)
103. X. Yang, B. Xie, L. Wang, Y. Qin, Z. J. Henneman and G. H. Nancollas: Influence of magnesium ions and amino acids on the nucleation and growth of hydroxyapatite. CrystEngComm 13, 1153-1158 (2011)
104. I. Fernandez-Tresguerres Hernandez-Gil, M. A. Alobera Gracia, M. del Canto Pingarron and L. Blanco Jerez: Physiological bases of bone regeneration II. The remodeling process. Med Oral Patol Oral Cir Bucal 11, E151-E157 (2006)
105. M. R. Allen, A. M. Erickson, X. Wang, D. B. Burr, R. B. Martin and S. J. Hazelwood: Morphological assessment of basic multicellular unit resorption parameters in dogs shows additional mechanisms of bisphosphonate effects on bone. Calcif Tissue Int 86, 67-71 (2010)
106. A. G. Robling, A. B. Castillo and C. H. Turner: Biomechanical and molecular regulation of bone remodeling. Annu Rev Biomed Eng 8, 455-498 (2006)
107. B. F. Boyce, Z. Yao and L. Xing: Osteoclasts have multiple roles in bone in addition to bone resorption. Crit Rev Eukaryot Gene Expr 19, 171-180 (2009)
108. C. Zhao, N. Irie, Y. Takada, K. Shimoda, T. Miyamoto, T. Nishiwaki, T. Suda and K. Matsuo: Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab 4, 111-121 (2006)
109. C.M. Edwards and G. R. Mundy: Eph receptors and ephrin signaling pathways: a role in bone homeostasis. Int J Med Sci 5, 263-272 (2008)
110. B. Frenkel, A. Hong, S. K. Baniwal, G. A. Coetzee, C. Ohlsson, O. Khalid and Y. Gabet: Regulation of adult bone turnover by sex steroids. J Cell Physiol 224, 305-310 (2010)
111. R. L. Jilka, R. S. Weinstein, T. Bellido, A. M. Parfitt and S. C. Manolagas: Osteoblast programmed cell death (apoptosis): Modulation by growth factors and cytokines. J Bone Miner Res 13, 793-802 (1998)
112. H. Kim, R. P. Camata, Y. K. Vohra and W. R. Lacefield: Control of phase composition in hydroxyapatite/tetracalcium phosphate biphasic thin coatings for biomedical applications. J Mater Sci Mater Med 16, 961-966 (2005)
113. H. S. Liu, T. S. Chin, L. S. Lai, S. Y. Chiu, K. H. Chung, C. S. Chang and M. T. Lui: Hydroxyapatite synthesized by a simplified hydrothermal method. Ceram Int 23, 19-25 (1997)
114. D. M. Liu, Q. Yang, T. Troczynski and W. J. Tseng: Structural evolution of sol-gel-derived hydroxyapatite. Biomaterials 23, 1679-1687 (2002)
115. W. L. Suchanek, P. Shuk, K. Byrappa, R. E. Riman, K. S. TenHuisen and V. F. Janas: Mechanochemical-hydrothermal synthesis of carbonated apatite powders at room temperature. Biomaterials 23, 699-710 (2002)
116. Y. M. Sung, J. C. Lee, and J. W. Yang: Crystallization and sintering characteristics of chemically precipitated hydroxyapatite nanopowder. J Cryst Growth 262, 467-472 (2004)
117. X. Guo, P. Xiao, J. Liu and Z. Shen: Fabrication of nanostructured hydroxyapatite via hydrothermal synthesis and spark plasma sintering. J Am Ceram Soc 88, 1026-1029 (2005)
118. F. Vazquez-Hernandez, C. Mendoza-Barrera, V. Altuzar, M. Melendez-Lira, M.A. Santana-Aranda and M. de la L. Olvera: Synthesis and characterization of hydroxyapatite nanoparticles and their application in protein adsorption. Mater Sci Eng B Solid State Mater Adv Technol 174, 290-295 (2010)
119. J. Cihlar, A. Buchal and M. Trunec: Kinetics of thermal decomposition of hydroxyapatite bioceramics. J Mater Sci 34, 6121-6131 (1999)
120. M. Akao, H. Aoki and K. Kato: Mechanical properties of sintered hydroxyapatite for prosthetic applications. J Mater Sci 16, 809-812 (1981)
121. A. Farzadi, M. Solati-Hashjin, F. Bakhshi and A. Aminian: Synthesis and characterization of hydroxyapatite/ß-Tricalcium phosphate nanocomposites using microwave irradiation. Ceram Int 37, 65-71 (2011)
122. C. P. A. T. Klein, A. A. Driessen and K. de Groot: Relationship between the degradation behaviour of calcium phosphate ceramics and their physical-chemical characteristics and ultrastructural geometry. Biomaterials 5, 157-160 (1984)
123. H. Wang, J. K. Lee, A. Moursi and J. J. Lannutti: Ca/P ratio effects on the degradation of hydroxyapatite in vitro. J Biomed Mater Res A 67A, 599-608 (2003)
124. H. Oonishi, L. L. Hench, J. Wilson, F. Sugihara, E. Tsuji, S. Kushitani and H. Iwaki: Comparative bone growth behavior in granules of bioceramic materials of various sizes. J Biomed Mater Res 44, 31-43 (1999)
125. P. Ducheyne, S. Radin and L. King: The effect of calcium phosphate ceramic composition and structure on in vitro behavior. I. Dissolution. J Biomed Mater Res 27, 25-34 (1993)
126. J.D. De Bruijn, Y.P. Bovell, J. E. Davies and C.A. van Blitterswijk: Osteoclastic resorption of calcium phosphates is potentiated in post osteogenic culture conditions. J Biomed Mater Res 28, 105-112 (1994)
127. A. Bigi, G. Cojazzi, S. Panzavolta, A. Ripamonti, N. Roveri, M. Romanello, K. Noris Suarez and L. Moro: Chemical and structural characterization of the mineral phase from cortical and trabecular bone. J Inorg Biochem 68, 45-51 (1997)
128. E. Landi, G. Celotti, G. Logroscino and A. Tampieri: Carbonated hydroxyapatite as bone substitute. J Eur Ceram Soc 23, 2931-2937 (2003)
129. T. J. Webster, E. A. Massa-Schlueter, J. L. Smith and E. B. Slamovich: Osteoblast response to hydroxyapatite doped with divalent and trivalent cations. Biomaterials 25, 2111-2121 (2004)
130. Z. P. Sun, B. Ercan, Z. Evis and T. J. Webster: Microstructural, mechanical, and osteocompatibility properties of Mg2+/F-doped nanophase hydroxyapatite J Biomed Mater Res A 94A, 806-815 (2010)
131. A. L. Rosa, M. M. Beloti and R. van Noort: Osteoblastic differentiation of cultured rat bone marrow cells on hydroxyapatite with different surface topography. Dent Mater 19, 768-772 (2003)
132. D. D. Deliglianni, N. D. Katsala, P. G. Koutsoukos and Y. F. Missirlis: Effect of surface roughness of hydroxyapatite on human bone marrow cell adhesion, proliferation, differentiation and detachment strength. Biomaterials 22, 87-96 (2001)
133. A. C. Jones, C. H. Arns, A. P. Sheppard, D. W. Hutmacher, B. K. Milthorpe and M. A. Knackstedt: Assessment of bone ingrowth into porous biomaterials using MICRO-CT. Biomaterials 28, 2491-2504 (2007)
134. F. R. Rose, L. A. Cyster, D. M. Grant, C. A. Scotchford, S. M. Howdle and K. M. K. M. Shakesheff: In vitro assessment of cell penetration into porous hydroxyapatite scaffolds with a central aligned channel. Biomaterials 25, 5507-5514 (2004)
135. A. Bignon, J. Chouteau, J. Chevalier, G. Fantozzi, J. P. Carret, P. Chavassieux, G. Boivin, M. Melin and D. Hartmann: Effect of micro-And macroporosity of bone substitutes on their mechanical properties and cellular response. J Mater Sci Mater Med 14, 1089-1097 (2003)
136. C. T. Buckley and K. U. O'Kelly: Fabrication and characterization of a porous multidomain hydroxyapatite scaffold for bone tissue engineering investigations. J Biomed Mater Res 93B, 459-467 (2010)
137. M. Okamoto, Y. Dohi, H. Ohgushi, H. Shimaoka, M. Ikeuchi, A. Matsushima, K. Yonemasu and H. Hosoi: Influence of the porosity of hydroxyapatite ceramics on in vitro and in vivo bone formation by cultured rat bone marrow stromal cells. J Mater Sci Mater Med 17, 327-336 (2006)
138. J. S. Toung, R. C. Ogle, R. F. Morgan and W. H. Lindsey: Repair of a rodent nasal critical-size osseous defect with osteoblast augmented collagen gel. Laryngoscope 109, 1580-1584 (1999)
139. D. W. Hutmacher: Scaffolds in tissue engineering bone and cartilage. Biomaterials 21, 2529-2543 (2000)
140. E. M. Noah, J. Chen, X. Jiao, I. Heschel and N. Pallua: Impact of sterilization on the porous design and cell behavior in collagen sponges prepared for tissue engineering. Biomaterials 23, 2855-2861 (2002)
141. Y. Xiao, H. Qian, W. G. Young and P. M. Bartold: Tissue engineering for bone regeneration using differentiated alveolar bone cells in collagen scaffolds. Tissue Eng 9, 1167-1177 (2003)
142. E. Donzelli, A. Salvadè, P. Mimo, M. Viganò, M. Morrone, R. Papagna, F. Carini, A. Zaopo, M. Miloso, M. Baldoni and G. Tredici: Mesenchymal stem cells cultured on a collagen scaffold: In vitro osteogenic differentiation. Arch Oral Biol 52, 64-73 (2007)
143. C. H. Lee, A. Singla and Y. Lee: Biomedical applications of collagen. Int J Pharm 221, 1-22 (2001)
144. A. Venien and D. Levieux: Differentiation of bovine from porcine gelatines using polyclonal anti-peptide antibodies in indirect and competitive indirect ELISA. J Pharm Biomed Anal 39, 418-424 (2005)
145. R. K. Schneider, A. Puellen, R. Kramann, K. Raupach, J. Bornemann, R. Knuechel, A. Pérez-Bouza and S. Neuss: The osteogenic differentiation of adult bone marrow and perinatal umbilical mesenchymal stem cells and matrix remodelling in three-dimensional collagen scaffolds. Biomaterials 31, 467-480 (2010)
146. N. F. Huang, J. Chu, R. J. Lee and S. Li: Biophysical and chemical effects of fibrin on mesenchymal stromal cell gene expression. Acta Biomater 6, 3947-3956 (2010)
147. L. Huang, Y. Y. Cheng, P. L. Koo, K. M. Lee, L. Qin, J. C. Y. Cheng and S. M. Kumta: The effect of hyaluronan on osteoblast proliferation and differentiation in rat calvarial-derived cell cultures. J Biomed Mater Res A 66A, 880-884 (2003)
148. V. Hamilton, Y. Yuan, D. A. Rigney, B. M. Chesnutt, A. D. Puckett, J. L. Ong, Y. Yang, W. O. Haggard, S. H. Elder and J. D. Bumgardner: Bone cell attachment and growth on well-characterized chitosan films. Polym Int 56, 641-647 (2007)
149. O. Jeon, S. J. Song, K.-J. Lee, M. H. Park, S.-H. Lee, S. K. Hahn, S. Kim and B.-S. Kim: Mechanical properties and degradation behaviors of hyaluronic acid hydrogels cross-linked at various cross-linking densities. Carbohyd Polym 70, 251-257 (2007)
150. S. Hurrell, G. E. Milroy and R. E. Cameron: The degradation of polyglycolide in water and deuterium oxide. Part I: the effect of reaction rate. Polymer 44, 1421-1424 (2003)
151. C. X. F. Lam, D. W. Hutmacher, J. T. Schantz, M. A. Woodruff, S. H. Teoh: Evaluation of polycaprolactone scaffold degradation for 6 months in vitro and in vivo. J Biomed Mater Res A 90A, 906-919 (2009)
152. S. Li and S. McCarthy: Influence of crystallinity and stereochemistry on the enzymatic degradation of polylactides. Macromolecules 32, 4454-4456 (1999)
153. P. Mainil-Varlet, R. Curtis and S. Gogolewski: Effect of in vivo and in vitro degradation on molecular and mechanical properties of various low-molecular-weight polylactides. J Biomed Mater Res 36, 360-380 (1997)
154. Z. Ge, Z. Jin, and T. Cao: Manufacture of degradable polymeric scaffolds for bone regeneration. Biomed Mater 3, 022001 (2008)
155. Z. Gugala and S. Gogolewski: Healing of critical-size segmental bone defects in the sheep tibiae using bioresorbable polylactide membranes. Injury, Int J Care injured 33, 71-76 (2002)
156. G. Ciapetti, L. Ambrosio, L. Savarino, D. Granchi, E. Cenni, N. Baldini, S. Pagani, S. Guizzardi, F. Causa and A. Giunti: Osteoblast growth and function in porous poly epsilon-caprolactone matrices for bone repair: a preliminary study. Biomaterials 24, 3815-3824 (2003)
157. J. T. Schantz, D. W. Hutmacher, K. W. Ng, H. L. Khor, T. C. Lim and S. H. Teoh: Evaluation of a tissue engineered membrane-cell construct for guided bone regeneration. Int J Oral Maxillofac Implants 17, 161-174 (2002)
158. S. H. Oh, I. K. Park, J. M. Kim and J. H. Lee: In vitro and in vivo characteristics of PCL scaffolds with pore size gradient fabricated by a centrifugation method. Biomaterials 28, 1664-1671 (2007)
159. Z. Gugala and S. Gogolewski: Differentiation, growth and activity of rat bone marrow stromal cells on resorbable poly(L/DL-lactide) membranes. Biomaterials 25, 2299-2307 (2004)
160. Z. G. Tang, J. T. Callaghan and J. A. Hunt: The physical properties and response of osteoblasts to solution cast films of PLGA doped polycaprolactone. Biomaterials 26, 6618-6624 (2005)
161. J. K. Park, J. Yeom, E. J. Oh, M. Reddy, J. Y. Kim, D. W. Cho, H. P. Lim, N. S. Kim, S. W. Park, H. I. Shin, D. J. Yang, K. B. Park and S. K. Hahn: Guided bone regeneration by poly(lactic-co-glycolic acid) grafted hyaluronic acid bi-layer films for periodontal barrier applications. Acta Biomater 5, 3394-3403 (2009)
162. S. Hong and G. Kim: Fabrication of electrospun polycaprolactone biocomposites reinforced with chitosan for the proliferation of mesenchymal stem cells. Carbohyd Polym 83, 940-946 (2011)
163. P. R. K-hasuwan, P. Pavasant and P. Supaphol: Effect of the surface topography of electrospun poly(e-caprolactone)/poly(3-hydroxybuterate-co-3- hydroxyvalerate) fibrous substrates on cultured bone cell behavior. Langmuir 27, 10938-10946 (2011)
164. V. Guarino, F. Causa, P. Taddei, M. di Foggia, G. Ciapetti, D. Martini, C. Fagnano, N. Baldini and L. Ambrosio: Polylactic acid fibre-reinforced polycaprolactone scaffolds for bone tissue engineering. Biomaterials 29, 3662-3670 (2008)
165. C. Bertoldi, D. Zaffe and U. Consolo: Polylactide/polyglycolide copolymer in bone defect healing in humans. Biomaterials 29, 1817-1823 (2008)
166. S. A. Martel-Estrada, C. A. Martinez-Pérez, J. G. Chacon-Nava, P. E. Garcia-Casillas and I. Olivas-Armendariz: In vitro bioactivity of chitosan/poly (D,Llactide-co-glycolide) composites. Mater Lett 65, 137-141 (2011)
167. L. Rimondini, N. Nicoli-Aldini, M. Fini, G. Guzzardella, M. Tschon and R. Giardino: In vivo experimental study on bone regeneration in critical bone defects using an injectable biodegradable PLA/PGA copolymer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99, 148-154 (2005)
168. S. J. Lee, G. J. Lim, J. W. Lee, A. Atala and J. J. Yoo: In vitro evaluation of a poly(lactide-co-glycolide)-collagen composite scaffold for bone regeneration. Biomaterials 27, 3466-3472 (2006)
169. P.-P. A. Vergroesen, R.-J. Kroeze, M. N. Helder and T. H. Smit: Bone tissue engineering: application in a spinal fusion model. Macromol Biosci 11, 722-730 (2011)
170. A. M. Henslee, P. P. Spicer, D. M. Yoon, M. B. Nair, V. V. Meretoja, K. E. Witherel, J. A. Jansen, A. G. Mikos and F. K. Kasper: Biodegradable composite scaffolds incorporating an intramedullary rod and delivering bone morphogenetic protein-2 for stabilization and bone regeneration in segmental long bone defects. Acta Biomater 7, 3627-3637 (2011)
171. M. Nagano, T. Kitsugi, T. Nakamura, T. Kokubo and M. Tanahashi: Bone bonding ability of an apatite-coated polymer produced using a biomimetic method: A mechanical and histological study in vivo. J Biomed Mater Res 31, 487-494 (1996)
172. Y. Liu, G. Wu and K. de Groot: Biomimetic coatings for bone tissue engineering of critical-sized defects. J R Soc Interface 7, S631-S647 (2010)
173. N. A. Badr and A. A. El Hadary: Hydroxyapatiteelectroplated cp-Titanium implant and its bone integration potentiality: an in vivo study. Implant Dent 16, 297-308 (2007)
174. K. Furuichi, Y. Oaki, H. Ichimiya, J. Komotori and H. Imai: Preparation of hierarchically organized calcium phosphate-organic polymer composites by calcification of hydrogel. Sci Technol Adv Mater 7, 219-225 (2006)
175. F. Yang, J.G.C. Wolke and J.A. Jansen: Biomimetic calcium phosphate coating on electrospun poly(e-caprolactone) scaffolds for bone tissue engineering. Chem Eng J 137, 154-161(2008)
176. B. Mavis, T. T. Demirtas, M. Gumusderelioglu, G. Gunduz and U. Colak. Synthesis, characterization and osteoblastic activity of polycaprolactone nanofibers coated with biomimetic calcium phosphate. Acta Biomater 5, 3098-3111 (2009)
177. X. Shi, J. Jiang, L. Sun and Z. Gan: Hydrolysis and biomineralization of porous PLA microspheres and their influence on cell growth. Colloids Surf B Biointerfaces 85, 73-80 (2011)
178. K. Gorna and S. Gogolewski: Preparation, degradation, and calcification of biodegradable polyurethane foams for bone graft substitutes. J Biomed Mater Res A 67A, 813-827 (2003)
179. C. Chan, I. Thompson, P. Robinson, J. Wilson and L. Hench: Evaluation of Bioglass/dextran composite as a bone graft substitute. Int J Oral and Maxillofac Surg 31, 73-77 (2002)
180. X. B. Yang, D. Webb, J. Blaker, A. R. Boccaccini, V. Maquet, C. Cooper and R. O. C. Oreffo: Evaluation of human bone marrow stromal cell growth on biodegradable polymer/Bioglass® composites. Biochem Biophys Res Commun 342, 1098-1107 (2006)
181. C. A. Scotchford, M. Shataheri, P.-S. Chen, M. Evans, A. J. Parsons, G. A. Aitchison, C. Efeoglu, J. L. Burke, A. Vikram, S. E. Fisher, and C. D. Rudd: Repair of calvarial defects in rats by prefabricated, degradable, long fibre composite implants. J Biomed Mater Res A 96A, 230-238 (2011)
182. M. C. Phipps, W. C. Clem, J. M. Grunda, G. A. Clines and S. L. Bellis: Increasing the pore sizes of bone-mimetic electrospun scaffolds comprised of polycaprolactone, collagen I and hydroxyapatite to enhance cell infiltration. Biomaterials 33, 524-534 (2012)
183. J.-P. Chen and Y.-S. Chang: Preparation and characterization of composite nanofibers of polycaprolactone and nanohydroxyapatite for osteogenic differentiation of mesenchymal stem cells. Colloids Surf B Biointerfaces 86, 169-175 (2011)
184. Z.-L. Mou, L.-J. Zhao, Q.-A. Zhang, J. Zhang and Z.-Q Zhang: Preparation of porous PLGA/HA/collagen scaffolds with supercritical CO2 and application in osteoblast cell culture. J Supercrit Fluids 58, 398-406 (2011)
185. J. A. Roether, A. R. Boccaccini, L. L. Hench, V. Maquet, S. Gautier and R. Jerome: Development and in vitro characterisation of novel bioresorbable and bioactive composite materials based on polylactide foams and Bioglass® for tissue engineering applications. Biomaterials 23, 3871-3878 (2002)
186. J. L. Ryszkowska, M. Auguscik, A. Sheikh, A. R. Boccaccini: Biodegradable polyurethane composite scaffolds containing Bioglass® for bone tissue engineering. Compos Sci Technol 70, 1894-1908 (2010)
187. A. Morawska-Chochol, J. Jaworska, J. Chlopek, J. Kasperczyk, P. Dobrzyñski, C. Paluszkiewicz and G. Bajor: Degradation of poly(lactide-co-glycolide) and its composites with carbon fibres and hydroxyapatite in rabbit femoral bone. Polym Degrad Stab 96, 719-726 (2011)
188. H. Wang, Y. Zuo, Q. Zou, L. Cheng, D. Huang, L. Wang and Y. Li: Nano-hydroxyapatite/polyamide66 composite tissue-engineering scaffolds with anisotropy in morphology and mechanical behaviors. J Polym Sci A Polym Chem 47, 658-669 (2009)
189. Y. Kang, A. Scully, D. A. Young, S. Kim, H. Tsao, M. Sen and Y. Yang: Enhanced mechanical performance and biological evaluation of a PLGA coated b-TCP composite scaffold for load-bearing applications. Eur Polym J 47, 1569-1577 (2011)
190. A. J. Wagoner Johnson and B. A. Herschler: A review of the mechanical behavior of CaP and CaP/polymer composites for applications in bone replacement and repair. Acta Biomater 7, 16-30 (2011)
191. R. E. Neuendorf, E. Saiz, A. P. Tomsia and R. O. Ritchie: Adhesion between biodegradable polymers and hydroxyapatite: Relevance to synthetic bone-like materials and tissue engineering scaffolds. Acta Biomater 4, 1288-1296 (2008)
192. M. Mattioli-Belmonte, G. Vozzi, Y. Whulanza, M. Seggiani, V. Fantauzzi, G. Orsini and A. Ahluwalia: Tuning polycaprolactone-carbon nanotube composites for bone tissue engineering scaffolds. Mater Sci Eng C 32, 152-159 (2012) doi:10.1016/j.msec.2011.10.010
193. M. Hindié, M. C. Degat, F. Gaudière, O. Gallet, P. R. Van Tassel and E. Pauthe: Pre-osteoblasts on poly(L-lactic acid) and silicon oxide: Influence of fibronectin and albumin adsorption. Acta Biomater 7, 387-394 (2011)
194. K. M. Woo, J. Seo, R. Zhang and P. X. Ma: Suppression of apoptosis by enhanced protein adsorption on polymer/hydroxyapatite composite scaffolds. Biomaterials 28, 2622-2630 (2007)
195. C. D. Reyes, T. A. Petrie, K. L. Burns, Z. Schwartz and A. J. Garcia: Biomolecular surface coating to enhance orthopaedic tissue healing and integration. Biomaterials 28, 3228-3235 (2007)
196. K. M. Hennessy, B. E. Pollot, W. C. Clem, M. C. Phipps, A. A. Sawyer, B. K. Culpepper and S. L. Bellis: The effect of collagen I mimetic peptides on mesenchymal stem cell adhesion and differentiation, and on bone formation at hydroxyapatite surfaces. Biomaterials 30, 1898-1909 (2009)
197. A. M. Wojtowicz, A. Shekaran, M. E. Oest, K. M. Dupont, K. L. Templeman, D. W. Hutmacher, R. E. Guldberg and A. J. Garcia: Coating of biomaterial scaffolds with the collagen-mimetic peptide GFOGER for bone defect repair. Biomaterials 31, 2574-2582 (2010)
198. G. Xie, J. Sun, G. Zhong, C. Liu and J. Wei: Hydroxyapatite nanoparticles as a controlled-release carrier of BMP-2: absorption and release kinetics in vitro. J Mater Sci Mater Med 21, 1875-1880 (2010)
199. S. E. Kim, S. H. Song, Y. P. Yun, B. J. Choi, I. K. Kwon, M. S. Bae, H. J. Moon and Y. D. Kwon: The effect of immobilization of heparin and bone morphogenic protein-2 (BMP-2) to titanium surfaces on inflammation and osteoblast function. Biomaterials 32, 366-373 (2011)
200. H. Zhou, T. Wu, X. Dong, Q. Wang and J. Shen: Adsorption mechanism of BMP-7 on hydroxyapatite (001) surfaces. Biochem Biophys Res Commun 361, 91-96 (2007)
201. S. Dohzono, Y. Imai, H. Nakamura, S. Wakitani and K. Takaoka: Successful spinal fusion by E. coli-derived BMP-2-Adsorbed porous betaTCP granules: A pilot study. Clin Orthop Relat Res 467, 3206-3212 (2009)
202. Y. Su, Q. Su, W. Liu, M. Lim, J. R. Venugopal, X. Mo, S. Ramakrishn, S. S. Al-Deyab and M. El-Newehy: Controlled release of bone morphogenetic protein 2 and dexamethasone loaded in core-shell PLLACL-collagen fibers for use in bone tissue engineering. Acta Biomater 8, 763-771 (2012)
203. T. Kirsch, J. Nickel and W. Sebald: BMP-2 antagonists emerge from alterations in the low-Affinity binding epitope for receptor BMPR-II. EMBO J 19, 3314-3324 (2000)
204. Y. Chen and T. J. Webster: Increased osteoblast functions in the presence of BMP-7 short peptides for nanostructured biomaterial applications. J Biomed Mater Res A 91A, 296-304 (2009)
205. A. Saito, Y. Suzuki, S.-i. Ogata, C. Ohtsuki and M. Tanihara: Activation of osteo-progenitor cells by a novel synthetic peptide derived from the bone morphogenetic protein-2 knuckle epitope. Biochim Biophys Acta 1651, 60-67 (2003)
206. Q. Yuan, H. Lu, S. Tang, K. Liu, Z. Pan, H. Pan, D. Quan, Q. Zheng and X. Guo: Ectopic bone formation in vivo induced by a novel synthetic peptide derived from BMP-2 using porous collagen scaffolds. J Wuhan Univ Techno Mat Sci Edit 22, 701-705 (2007)
207. X. Niu, Q. Feng,M. Wang, X. Guo and Q. Zheng: Porous nano-HA/collagen/ PLLA scaffold containing chitosan microspheres for controlled delivery of synthetic peptide derived from BMP-2. J Control Release 134, 111-117 (2009)
208. Y. Suzuki, M. Tanihara, K. Suzuki, A. Saitou, W. Sufan and Y. Nishimura: Alginate hydrogel linked with synthetic oligopeptide derived from BMP-2 allows ectopic osteoinduction in vivo. J Biomed Mater Res 50, 405-409 (2000)
209. A. Saito, Y. Suzuki, M. Kitamura, S. I. Ogata, Y. Yoshihara, S. Masuda, C. Ohtsuki and M. Tanihara: Repair of 20-mm long rabbit radial bone defects using BMP-derived peptide combined with an alphatricalcium phosphate scaffold. J Biomed Mater Res A 77A, 700-706 (2006)
210. J. W. Shen, T. Wu, Q. Wang and H. H. Pan: Molecular simulation of protein adsorption and desorption on hydroxyapatite surfaces. Biomaterials 29, 513-532 (2008)
211. D. Klee, Z. Ademovic, A. Bosserhoff, H. Hoecker, G. Maziolis and H. J. Erli: Surface modification of poly(vinylidenefluoride) to improve the osteoblast adhesion. Biomaterials 24, 3663-3670 (2003)
212. J. D. Andrade and V. Hlady: Protein adsorption and materials biocompatibility: A tutorial review and suggested hypotheses. Biopolymers/Non-Exclusion HPLC, Springer Berlin / Heidelberg, pp. 1-63 (1986)
213. R. Kluger and A. Alagic: Chemical cross-linking and protein-protein interactions-A review with illustrative protocols. Bioorg Chem 32, 451-472 (2004)
214. E. J. M. Tournier, J. Wallach and P. Blond: Sulfosuccinimidyl 4-(N-maleimidomethyl)-1-cyclohexane carboxylate as a bifunctional immobilization agent. Optimization of the coupling conditions. Anal Chim Acta 361, 33-44 (1998)
215. C. Bieniarz, M. Husain, G. Barnes, C. A. King and C. J. Welch: Extended Length Heterobifunctional Coupling Agents for Protein Conjugations. Bioconjug Chem 7, 88-95 (1996)
216. S. Guttmann, R. Boissonnas and J. Pless: Protection of the guanidine group of arginine during peptide synthesis by the pnitrocarbobenzoxy group. Patent US3388113
217. A. Karlström and A. Undén: A new protecting group for aspartic acid that minimizes piperidine-catalyzed aspartimide formation in Fmoc solid phase peptide synthesis. Tetrahedron Lett 37, 4243-4246 (1996)
218. A. Rezania and K. E. Healy: Biomimetic peptide surfaces that regulate adhesion, spreading, cytoskeletal organisation, and mineralisation of the matrix deposited by osteoblast-like cells. Biotechnol Prog 15, 19-32 (1999)
219. H. Suh, Y.-S. Hwang, J.-E. Lee, C. D. Han and J.-C. Park: Behavior of osteoblasts on a type I atelocollagen grafted ozone oxidized poly L-lactic acid membrane. Biomaterials 22, 219-230 (2001)
220. Y. Zhang, C. Chai, X. S. Jiang, S. H. Teoh and K. W. Leong: Fibronectin immobilized by covalent conjugation or physical adsorption shows different bioactivity on aminated-PET.Mater Sci Eng C Mater Biol Appl 27, 213-219 (2007)
221. H. Chen, L. Yuan, W. Song, Z. Wu and D. Li: Biocompatible polymer materials: Role of protein-surface interactions Prog Polym Sci 33, 1059-1087 (2008)
222. W.-B. Tsai, Y.-R. Chen, H.-L. Liu and J.-Y. Lai: Fabrication of UV-crosslinked chitosan scaffolds with conjugation of RGD peptides for bone tissue engineering. Carbohydr Polym 85, 129-137 (2011)
223. D. S. W. Benoit and K. S. Anseth: The effect on osteoblast function of colocalized RGD and PHSRN epitopes on PEG surfaces. Biomaterials 26, 5209-5220 (2005)
224. S. E. Ochsenhirt, E. Kokkoli, J. B. McCarthy and M. Tirrell: Effect of RGD secondary structure and the synergy site PHSRN on cell adhesion, spreading and specific integrin engagement. Biomaterials 27, 3863-3874 (2006)
225. L. Y. Santiago, R. W. Nowak, J. Peter Rubin and K. G. Marra: Peptide-surface modification of poly(caprolactone) with laminin-derived sequences for adipose-derived stem cell applications. Biomaterials 27, 2962-2969 (2006)
226. C. M. Cowan, Y. Y. Shi, O. O. Aalami, Y. F. Chou, C. Mari, R. Thomas, N. Quarto, C. H. Contag, B. Wu and M. T. Longaker: Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotech 22, 560-567 (2004)
227. J. W. Kim, C. S. Ki, Y. H. Park, H. J. Kim and I. C. Um: Effect of RGDS and KRSR peptides immobilized on silk fibroin nanofibrous mats for cell adhesion and proliferation. Macromol Res 18, 442-448 (2010)
228. R. A. Stile and K. E. Healy: Thermo-responsive peptide-modified hydrogels for tissue regeneration. Biomacromolecules 2, 185-194 (2001)
229. G. M. Harbers and K. E. Healy: The effect of ligand type and density on osteoblast adhesion, proliferation, and matrix mineralization. J Biomed Mater Res A 75A, 855-869 (2005)
230. A. Saito, Y. Suzuki, S. I. Ogata, C. Ohtsuki and M. Tanihara: Prolonged ectopic calcification induced by BMP-2 derived synthetic peptide. J Biomed Mater Res A 70A, 115-121 (2004)
231. N. Adden, L. J. Gamble, D. G. Castner, A. Hoffmann, G. Gross and H. Menzel: Synthesis and characterization of biocompatible polymer interlayers on titanium implant materials. Biomacromolecules 7, 2552-2559 (2006)
232. H. Zhang, F. Migneco, C. Y. Lin and S. J. Hollister: Chemically- conjugated bone morphogenetic protein-2 on three-dimensional polycaprolactone scaffolds stimulates osteogenic activity in bone marrow stromal cells. Tissue Eng Part A. 16, 3441-3448 (2010)
233. Z. Duan, Q. Zheng, X. Guo, Q. Yuan and S. Chen: Experimental research on ectopic osteogenesis of BMP2-derived peptide P24 combined with PLGA copolymers. J Huazhong Univ Sci Technolog Med Sci 27, 179-182 (2007)
234. K. Kirkwood, B. Rheude, Y. J. Kim, K. White and K. C. Dee: In vitro mineralization studies with substrateimmobilized bone morphogenetic protein peptides. J Oral Implantol 29, 57-65 (2003)
235. X. He, J. Ma and E. Jabbari. Effect of grafting RGD and BMP-2 protein-derived peptides to a hydrogel substrate on osteogenic differentiation of marrow stromal cells. Langmuir 24, 12508-12516 (2008)
236. J. S. Park, H. N. Yang, S. Y. Jeon, D. G. Woo, K. Na and K.-H. Park: Osteogenic differentiation of human mesenchymal stem cells using RGD-modified BMP-2 coated microspheres. Biomaterials 31, 6239-6248 (2010)
237. Y. Tamura, Y. Takeuchi, M. Suzawa, S. Fukumoto, M. Kato, K. Miyazono and T. Fujita: Focal adhesion kinase activity is required for bone morphogenetic protein-Smad1 signaling and osteoblastic differentiation in murine MC3T3-E1 cells. J Bone Miner Res 16, 1772-1779 (2001)
238. N. M. Moore, N. J. Lin, N. D. Gallant and M. L. Becker: Synergistic enhancement of human bone marrow stromal cell proliferation and osteogenic differentiation on BMP-2-derived and RGD peptide concentration gradients. Acta Biomater 7, 2091-2100 (2011)
239. M.-E. Marquis, E. Lord, E. Bergeron, L. Bourgoin and N. Faucheux: Short-Term effects of adhesion peptides on the responses of preosteoblasts to pBMP-9. Biomaterials 29, 1005-1016 (2008)
240. O. Drevelle, E. Bergeron, H. Senta, M.-A. Lauzon, S. Roux, G. Grenier and N. Faucheux: Effect of functionalized polycaprolactone on the behaviour of murine preosteoblasts. Biomaterials 31, 6468-6476 (2010)
241. K. M. Hennessy, W. C. Clem, M. C. Phipps, A. A. Sawyer, F. M. Shaikh and S. L. Bellis: The effect of RGD peptides on osseointegration of hydroxyapatite biomaterials. Biomaterials 29, 3075-3083 (2008)
242. S. Tosatti, S. M. D. Paul, A. Askendal, S. VandeVondele, J. A. Hubbell, P. Tengvall and M. Textor: Peptide functionalized poly(L-lysine)-g-poly(ethylene glycol) on titanium: resistance to protein adsorption in full heparinized human blood plasma. Biomaterials 24, 4949-4958 (2003)
243. C. J. Brinkerhoff and J. J. Linderman: Integrin dimerization and ligand organization: Key components in integrin clustering for cell adhesion. Tissue Eng 11, 865-876 (2005)
244. W. A. Comisar, D. J. Mooney and J. J. Linderman: Integrin organization: Linking adhesion ligand nanopatterns with altered cell responses. J Theor Biol 274, 120-130 (2011)
245. S. X. Hsiong, P. Carampin, H. J. Kong, K. Y. Lee and D. J. Mooney: Differentiation stage alters matrix control of stem cells. J Biomed Mater Res A 85A, 145-156 (2008)
246. A. Rezania and K. E. Healy: The effect of peptide surface density on mineralization of a matrix deposited by osteogenic cells. J Biomed Mater Res 52, 595-600 (2000)
247. S. J. Bogdanowich-Knipp, S. Chakrabarti, T. D. Williams, R. K. Dillman and T. J. Siahaan: Solution stability of linear vs. cyclic RGD peptides. J Pept Res 53, 530-541 (1999)
248. N. Huebsch, M. Gilbert and K. E. Healy: Analysis of sterilization protocols for peptide-modified hydrogels. J Biomed Mater Res Part B: Appl Biomater 74B: 440-447 (2005)
249. Y. C. Tyan, J. D. Liao, S. P. Lin and C. C. Chen: The study of the sterilization effect of gamma ray irradiation of immobilized collagen polypropylene nonwoven fabric surfaces. J Biomed Mater Res A. 67A, 1033-1043 (2003)